RECRUITING

Measuring Surgical Recovery After Radical Cystectomy

Talk to us

Conditions

Bladder CancerRegistryPost-surgical outcomesRadical cystectomyMD Anderson Symptom inventoryMDASI

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clinician-reported outcomes (CRO) as well as various presenting conditions associated with them, so that future quality improvement interventions can be evaluated accurately as to their relative contribution to improved outcomes.

Official Title

Measuring Surgical Recovery After Radical Cystectomy

Quick Facts

Study Start:2015-04-30
Study Completion:2034-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03193970

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Bladder cancer patients undergoing radical cystectomy at the MD Anderson Cancer Center and the collaborating centers.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Neema Navai, MD
CONTACT
713-792-3950
nnavai@mdanderson.org

Principal Investigator

Neema Navai, MD
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

University of California - San Francisco
San Francisco, California, 94143
United States
Stanford University
Stanford, California, 94305
United States
Emory University
Atlanta, Georgia, 30322
United States
University of Chicago
Chicago, Illinois, 60637
United States
University of Kansas Medical Center
Lawrence, Kansas, 66045
United States
John Hopkins Medical Institutions
Baltimore, Maryland, 21205
United States
Spectrum Health Medical Group
Grand Rapids, Michigan, 49503
United States
Winthrop University Hospital
Mineola, New York, 11501
United States
University of Rochester
Rochester, New York, 14611
United States
University of Texas - Southwestern
Dallas, Texas, 75390
United States
University of Texas MD Anderson Cancer Center
Houston, Texas, 77339
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Neema Navai, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-04-30
Study Completion Date2034-12-31

Study Record Updates

Study Start Date2015-04-30
Study Completion Date2034-12-31

Terms related to this study

Keywords Provided by Researchers

  • Bladder Cancer
  • Registry
  • Post-surgical outcomes
  • Radical cystectomy
  • MD Anderson Symptom inventory
  • MDASI

Additional Relevant MeSH Terms

  • Bladder Cancer